Long-term prophylaxis in venous thromboembolism: LMWH or oral anticoagulation?

Haemostasis

Volumn 28, Issue SUPPL. 3, 1998, Pages 17-21

  Schulman, Sam ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Low molecular weight heparin; Pregnancy; Prophylaxis; Venous thromboembolism; Warfarin

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT PLANNING; VEIN THROMBOSIS;

EID: 0032465513     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022401     Document Type: Conference Paper

References (15)

1. Hull RD, Delmore T, Genton E, Hirsh J, Gent M, Sackett D, McLoughlin D, Armstrong P: Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979;301:855-858.
2. Bynum LJ, Wilson JE: Low-dose heparin therapy in the the long-term management of venous thromboembolism. Am J Med 1979;67:553-556.
3. Wessler S, Gitel SN: Rethrombosis - warfarin or low-dose heparin. N Engl J Med 1979;301:889-891.
4. Sánchez J, Olsson P: On the control of the plasma contact activation system on human endothelium. Comparisons with heparin surface. Thromb Res 1998 (In press).
5. Hull R, Delmore T, Carter C, Hirsh J, Genton E, Gent M, Turpie AG, McLaughlin D: Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 1982;306:189-194.
6. Harenberg J, Leber G, Augustin J, Raedsch R, Schwarz F, Stiehl A, Zimmermann R: Ambulatory long-term prevention of thromboembolism with low-molecular weight heparin. Klin Wochenschr 1987;65:331-337.
7. Vitoux J-F, Fiessinger J-N, Roncato M, Pernes J-M, Brenot P, Aiach M: Long-term treatment of acute deep venous thrombosis with a low-molecular-weight heparin derivative. JAMA 1988;259:1180-1181.
8. Priollet P, Roncato M, Aiach M, Housset E, Poissonnier MH, Chavinie J: Low-molecular-weight heparin in venous thrombosis during pregnancy. Br J Haematol 1986;63:605-606.
9. Harenberg J, Leber G, Zimmermann R, Schmidt W: Thromboembolieprophylaxe mit niedermolekularem Heparin in der Schwangerschaft. Geburtsh Frauenheilk 1987;47:15-18.
10. Hunt BJ, Doughty H-A, Majumdar G, Copplestone A, Kerslake S, Buchanan L, Hughes G, Khamashta M: Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost 1997;77:39-43.
11. Monreal M, Lafoz E, Olive A, del Rio L, Vedia C: Comparison of subcutaneous unfractionated heparin with a low-molecular-weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 1994;71:7-11.
12. Pini M, Aiello S, Manotti C, Pattachini C, Quintavalla R, Poli T, Tagliaferri A, Detton AG: Low-molecular-weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemost 1994;72:191-197.
13. Das SK, Cohen AT, Edmondson RA, Melissari E, Kakkar W: Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial. World J Surg 1996;20:521-527.
14. Schulman S: Optimal duration of oral anticoagulant therapy in venous thromboembolism. Thromb Haemost 1997;78:693-698.
15. Kock HJ, Schmit-Neuerburg KP, Hanke J, Rudofsky G, Hirche H: Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg. Lancet 1995;346:459-461.